View all news

    Janssen reports positive top-line Phase 3 results for ponesimod in adults with relapsing multiple sclerosis

    07/25/2019
    Download(opens in new window)PDF 179 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com